NCT02574793View on ClinicalTrials.gov

Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

January 7, 2018

Conditions
Pituitary Adenoma
Interventions
DEVICE

continuous glucose monitoring

Patients newly diagnosed GH-releasing pituitary adenoma or Cushing Syndrome in our department will be monitored blood glucose by CGMS Gold.

Trial Locations (1)

20041

Xiaolong Zhao, Jing’an

All Listed Sponsors
lead

Huashan Hospital

OTHER

NCT02574793 - Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects | Biotech Hunter | Biotech Hunter